{"id":"NCT00639158","sponsor":"Abbott","briefTitle":"Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood","officialTitle":"A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2008-10","completion":null,"firstPosted":"2008-03-20","resultsPosted":"2009-11-05","lastUpdate":"2011-06-13"},"enrollment":543,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dyslipidemias","Coronary Heart Disease","Combined (Atherogenic) Dyslipidemia","Mixed Dyslipidemia"],"interventions":[{"type":"DRUG","name":"ABT-335","otherNames":["TriLipix","Fenofibric acid","Choline Fenofibrate"]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"atorvastatin","otherNames":["Lipitor"]},{"type":"DRUG","name":"ezetimibe","otherNames":["Ezetrol","Zetia","Ezemibe"]}],"arms":[{"label":"ABT-335 + atorvastatin + ezetimibe","type":"ACTIVE_COMPARATOR"},{"label":"Placebo + atorvastatin + ezetimibe","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to compare the safety and efficacy of ABT-335 (investigational drug) coadministered with atorvastatin and ezetimibe to atorvastatin coadministered with ezetimibe in subjects with abnormal lipid (fat) levels in the blood.","primaryOutcome":{"measure":"Median Percent Change in Triglycerides From Baseline to Final Visit","timeFrame":"Baseline to 12 Weeks (Final Visit)","effectByArm":[{"arm":"ABT-335 + 40 mg Atorvastatin + 10 mg Ezetimibe","deltaMin":-57.3,"sd":22.32},{"arm":"Placebo + 40 mg Atorvastatin + 10 mg Ezetimibe","deltaMin":-39.7,"sd":29.44}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":118,"countries":["United States"]},"refs":{"pmids":["20934572"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":272},"commonTop":["Muscle Spasms","Myalgia","Arthralgia","Fatigue","Diarrhea"]}}